Literature DB >> 22171133

Continuous regional arterial infusion and laparotomic decompression for severe acute pancreatitis with abdominal compartment syndrome.

Zhi-Gang Deng1, Jian-Yin Zhou, Zhen-Yu Yin, You-Yuan Peng, Fu-Qiang Wang, Xiao-Min Wang.   

Abstract

AIM: To evaluate the therapeutic effects of abdominal decompression plus continuous regional arterial infusion (CRAI) via a drug delivery system (DDS) in severe acute pancreatitis (SAP) patients with abdominal compartment syndrome (ACS).
METHODS: We presented our recent experience in 8 patients with SAP. The patients developed clinical ACS, which required abdominal decompression. During the operation, a DDS was inserted into the peripancreatic artery (the catheter was inserted from the right gastroepiploic artery until it reached the junction between the pancreaticoduodenal and gastroduodenal artery). Through this DDS, a protease inhibitor, antibiotics and octreotide were infused continuously. The duration of the regional artery infusion ranged from 8 to 41 d. The outcomes and the changes in the APACHE II score, computed tomography (CT) severity index and intra-abdominal pressure (IAP) of the patients were retrospectively evaluated.
RESULTS: Eight patients with an initial APACHE IIscore of 18.9 (range, 13-27) and a Balthazar CT severity index of 9.1 (range, 7-10) developed severe local and systemic complications. These patients underwent subsequent surgical decompression and CRAI therapy because of intra-abdominal hypertension (IAH). After a mean interval of 131.9 ± 72.3 d hospitalization, 7 patients recovered with decreased APACHE II scores, CT severity indexes and IAP. The mean APACHE II score was 5.4 (range, 4-8), the CT severity index was 2.3 (range, 1-3), and IAP decreased to 7.7 mmHg (range, 6-11 mmHg) 60 d after operation. One patient died of multiple organ failure 1 wk after surgery.
CONCLUSION: CRAI and laparotomic decompression might be a therapeutic option for SAP patients with ACS.

Entities:  

Keywords:  Abdominal compartment syndrome; Arterial infusion; Laparotomy; Severe acute pancreatitis

Mesh:

Year:  2011        PMID: 22171133      PMCID: PMC3235635          DOI: 10.3748/wjg.v17.i44.4911

Source DB:  PubMed          Journal:  World J Gastroenterol        ISSN: 1007-9327            Impact factor:   5.742


  28 in total

1.  Efficacy of continuous regional arterial infusion of a protease inhibitor and antibiotic for severe acute pancreatitis in patients admitted to an intensive care unit.

Authors:  Hiroshi Imaizumi; Mitsuhiro Kida; Hiroshi Nishimaki; Junko Okuno; Yuichi Kataoka; Yoshiki Kida; Kazui Soma; Katsunori Saigenji
Journal:  Pancreas       Date:  2004-05       Impact factor: 3.327

Review 2.  Management of infection in acute pancreatitis.

Authors:  Werner Hartwig; Jens Werner; Waldemar Uhl; Markus W Büchler
Journal:  J Hepatobiliary Pancreat Surg       Date:  2002

3.  APACHE II: a severity of disease classification system.

Authors:  W A Knaus; E A Draper; D P Wagner; J E Zimmerman
Journal:  Crit Care Med       Date:  1985-10       Impact factor: 7.598

4.  Abdominal compartment syndrome in severe acute pancreatitis: an indication for a decompressing laparotomy?

Authors:  Gary Gecelter; Bashar Fahoum; Syed Gardezi; Moshe Schein
Journal:  Dig Surg       Date:  2002       Impact factor: 2.588

5.  Prophylactic antibiotic administration reduces sepsis and mortality in acute necrotizing pancreatitis: a meta-analysis.

Authors:  V K Sharma; C W Howden
Journal:  Pancreas       Date:  2001-01       Impact factor: 3.327

6.  Continuous regional arterial infusion (CRAI) therapy reduces the mortality rate of acute necrotizing pancreatitis: results of a cooperative survey in Japan.

Authors:  K Takeda; S Matsuno; M Ogawa; S Watanabe; Y Atomi
Journal:  J Hepatobiliary Pancreat Surg       Date:  2001

7.  APACHE-II score for assessment and monitoring of acute pancreatitis.

Authors:  M Larvin; M J McMahon
Journal:  Lancet       Date:  1989-07-22       Impact factor: 79.321

8.  Acute pancreatitis, bacterial translocation, and different octreotide regimens: an experimental study.

Authors:  Osman Güler; Saadet Akturan; Erol Kisli; Iştar Dolapçi; Muzaffer Caydere; Atilla Akova
Journal:  Surg Today       Date:  2009-09-27       Impact factor: 2.549

9.  The effect of continuous arterial infusion of gabexate mesilate (FOY-007) on experimental acute pancreatitis.

Authors:  Hirohiko Satoh; Masamitsu Harada; Seiki Tashiro; Tsutomu Shiroya; Haruo Imawaka; Koji Machii
Journal:  J Med Invest       Date:  2004-08

10.  Persistent organ failure during the first week as a marker of fatal outcome in acute pancreatitis.

Authors:  C D Johnson; M Abu-Hilal
Journal:  Gut       Date:  2004-09       Impact factor: 23.059

View more
  3 in total

1.  The Decrease of Peripheral Blood CD4+ T Cells Indicates Abdominal Compartment Syndrome in Severe Acute Pancreatitis.

Authors:  Yao Liu; Ling Wang; Zhifang Cai; Peng Zhao; Cijun Peng; Lijin Zhao; Chidan Wan
Journal:  PLoS One       Date:  2015-08-19       Impact factor: 3.240

2.  Minimally invasive procedures in severe acute pancreatitis treatment - assessment of benefits and possibilities of use.

Authors:  Jacek Szeliga; Marek Jackowski
Journal:  Wideochir Inne Tech Maloinwazyjne       Date:  2014-04-01       Impact factor: 1.195

Review 3.  Interventional Treatment of Abdominal Compartment Syndrome during Severe Acute Pancreatitis: Current Status and Historical Perspective.

Authors:  Dejan V Radenkovic; Colin D Johnson; Natasa Milic; Pavle Gregoric; Nenad Ivancevic; Mihailo Bezmarevic; Dragoljub Bilanovic; Vladimir Cijan; Andrija Antic; Djordje Bajec
Journal:  Gastroenterol Res Pract       Date:  2015-12-29       Impact factor: 2.260

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.